Moderna CEO: “Less effective vaccines against the Omicron variant”

LONDON – Covid vaccines could be less effective against the Omicron variant: this is the prediction of Stéphane Bancel, CEO of Moderna, one of the pharmaceutical companies that have successfully produced a serum for the coronavirus. Bancel’s warning, interviewed by Financial Times at the headquarters of his company in the United States, contradicts the claims of the executives of Pfizer, another of the pharmaceutical companies producing a vaccine for Covid, and of the American president Joe Biden on the ability of current remedies to fight the mutation that emerged in the South Africa.